Trade Summary

3 months ago, Barry Richard, serving as Pres, CEO at Cassava Sciences Inc (SAVA), purchased 237,941 shares at $2.25 per share, for a total transaction value of $534,743.00. Following this transaction, Barry Richard now holds 707,503 shares of SAVA.

This purchase represents a 51.00% increase in Barry Richard's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, September 18, 2025 and publicly disclosed via SEC Form 4 filing on Monday, September 22, 2025, 4 days after the trade was made.

Cassava Sciences Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.